Literature DB >> 28807

The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.

P P Humphrey.   

Abstract

1 5-Hydroxytryptamine (5-HT) contracted isolated saphenous vein strips of the dog, producing a biphasic concentration-effect curve. The first phase occurred with low concentrations of 5-HT (1.0 X 10(-8) TO 5.0 X 10(-6) mol/l) with a plateau between 1.0 x 10(-6) mol/l and 1.0 x 10(-5) mol/l. The second phase occurred with high concentrations of 5-HT (greater than 1.0 x 10(-5) mol/l). 2 The alpha-adrenoceptor antabonists, phentolamine (5.0 x 10(-8) to 5.0 x 10(-7) mol/l), labetalol (1.0 x 10(-6) to 1.0 x 10(-5) mol/l) and thymoxamine (1.0 x 10(-6) to 1.0 x 10(-5) mol/l), antagonized responses to high concentrations of 5-HT but responses to low concentrations of 5-HT were not antagonized. 3 The effects of high concentrations of 5-HT were antagonized by cocaine (1.0 x 10(-6) to 1.0 x 10(-5) mol/l) and were not evident in veins removed from dogs pretreated with syrosingopine. 5-HT receptors and that high concentrations of 5-HT also act indirectly on alpha-adrenoceptors by displacing noradrenaline from neuronal stores.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28807      PMCID: PMC1668113          DOI: 10.1111/j.1476-5381.1978.tb17281.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  CHARACTERISTICS OF NOREPINEPHRINE RETENTION BY A SUBCELLULAR FRACTION OF RABBIT HEART.

Authors:  C N GILLIS
Journal:  J Pharmacol Exp Ther       Date:  1964-10       Impact factor: 4.030

2.  Theories of drug antagonism.

Authors:  J H GADDUM
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

3.  The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein.

Authors:  P P Humphrey
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

4.  The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.

Authors:  W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Influence of serotonin on adrenergic mechanisms.

Authors:  J Jester; W D Horst
Journal:  Biochem Pharmacol       Date:  1972-02-01       Impact factor: 5.858

6.  Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.

Authors:  J R Fozard
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

7.  Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118).

Authors:  F B ORLANS; K F FINGER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-02       Impact factor: 4.030

8.  Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit.

Authors:  J R Fozard; G M Mwaluko
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

9.  An action of 5-hydroxytryptamine on adrenaline receptors.

Authors:  I R INNES
Journal:  Br J Pharmacol Chemother       Date:  1962-12

10.  Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.

Authors:  E Apperley; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

View more
  11 in total

1.  Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification.

Authors:  G R Martin; S J MacLennan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonist, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations.

Authors:  C R Cain; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.

Authors:  E Apperley; W Feniuk; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

4.  5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.

Authors:  S J MacLennan; M J Whittle; J C McGrath
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

5.  Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro.

Authors:  C Forster; E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

6.  Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

7.  Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.

Authors:  M J Sumner; W Feniuk; J D McCormick; P P Humphrey
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

8.  A pharmacological analysis of receptors mediating the excitatory response to 5-hydroxytryptamine in the guinea-pig isolated trachea.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; M Tonini
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein.

Authors:  A D Medhurst; G E Novotny; S G Parker; N M Deighton; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

10.  Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.

Authors:  J L Black; R J French; E J Mylecharane
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.